Daphne N Voormolen, J Hans DeVries, Rieneke M E Sanson, Martijn P Heringa, Harold W de Valk, Marjolein Kok, Aren J van Loon, Klaas Hoogenberg, Dick J Bekedam, Teri C B Brouwer, Martina Porath, Ronald J Erdtsieck, Bas NijBijvank, Huib Kip, Olivier W H van der Heijden, Lammy D Elving, Brenda B Hermsen, B J Potter van Loon, Robert J P Rijnders, Henry J Jansen, Josje Langenveld, Bettina M C Akerboom, Rosalie M Kiewiet, Christiana A Naaktgeboren, Ben W J Mol, Arie Franx, Inge M Evers
AIM: Diabetes is associated with a high risk for adverse pregnancy outcomes. Optimal glycaemic control is fundamental and is traditionally monitored with self-measured glucose profiles and periodical HbA1c measurements. We investigated the effectiveness of additional use of retrospective Continuous Glucose Monitoring (CGM) in diabetic pregnancies. MATERIAL AND METHODS: We performed a nation wide multicentre open label randomised controlled trial studying pregnant women with type 1 diabetes, or type 2 diabetes on insulin therapy with gestational age <16 weeks, or insulin treated gestational diabetes with gestational age <30 weeks...
March 30, 2018: Diabetes, Obesity & Metabolism